Aberrant activation of EGFR caused by various alterations such as copy number amplification, mutations, and protein overexpression has been reported in the majority of human cancers, including bladder, breast, colon, head and neck, kidney, liver, lung, ovary, pancreas, prostate, and stomach cancers [10]. Here, EGFR is linked to cancer.